204 related articles for article (PubMed ID: 34428130)
1. Association between Intermittent Hypoxemia and Severe Bronchopulmonary Dysplasia in Preterm Infants.
Jensen EA; Whyte RK; Schmidt B; Bassler D; Vain NE; Roberts RS;
Am J Respir Crit Care Med; 2021 Nov; 204(10):1192-1199. PubMed ID: 34428130
[No Abstract] [Full Text] [Related]
2. Association Between Intermittent Hypoxemia or Bradycardia and Late Death or Disability in Extremely Preterm Infants.
Poets CF; Roberts RS; Schmidt B; Whyte RK; Asztalos EV; Bader D; Bairam A; Moddemann D; Peliowski A; Rabi Y; Solimano A; Nelson H;
JAMA; 2015 Aug; 314(6):595-603. PubMed ID: 26262797
[TBL] [Abstract][Full Text] [Related]
3. Physiology and Predictors of Impaired Gas Exchange in Infants with Bronchopulmonary Dysplasia.
Svedenkrans J; Stoecklin B; Jones JG; Doherty DA; Pillow JJ
Am J Respir Crit Care Med; 2019 Aug; 200(4):471-480. PubMed ID: 30789787
[No Abstract] [Full Text] [Related]
4. Cardiorespiratory Monitoring Data to Predict Respiratory Outcomes in Extremely Preterm Infants.
Ambalavanan N; Weese-Mayer DE; Hibbs AM; Claure N; Carroll JL; Moorman JR; Bancalari E; Hamvas A; Martin RJ; Di Fiore JM; Indic P; Kemp JS; Dormishian A; Krahn KN; Qiu J; Dennery PA; Ratcliffe SJ; Troendle JF; Lake DE;
Am J Respir Crit Care Med; 2023 Jul; 208(1):79-97. PubMed ID: 37219236
[No Abstract] [Full Text] [Related]
5. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
Kirpalani H; Ratcliffe SJ; Keszler M; Davis PG; Foglia EE; Te Pas A; Fernando M; Chaudhary A; Localio R; van Kaam AH; Onland W; Owen LS; Schmölzer GM; Katheria A; Hummler H; Lista G; Abbasi S; Klotz D; Simma B; Nadkarni V; Poulain FR; Donn SM; Kim HS; Park WS; Cadet C; Kong JY; Smith A; Guillen U; Liley HG; Hopper AO; Tamura M;
JAMA; 2019 Mar; 321(12):1165-1175. PubMed ID: 30912836
[TBL] [Abstract][Full Text] [Related]
6. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
Farhath S; He Z; Nakhla T; Saslow J; Soundar S; Camacho J; Stahl G; Shaffer S; Mehta DI; Aghai ZH
Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400
[TBL] [Abstract][Full Text] [Related]
7. Intermittent Hypoxemia and Bronchopulmonary Dysplasia with Pulmonary Hypertension in Preterm Infants.
Gentle SJ; Travers CP; Nakhmani A; Indic P; Carlo WA; Ambalavanan N
Am J Respir Crit Care Med; 2023 Apr; 207(7):899-907. PubMed ID: 36449386
[No Abstract] [Full Text] [Related]
8. Clinically unsuspected hypoxia during sleep and feeding in infants with bronchopulmonary dysplasia.
Garg M; Kurzner SI; Bautista DB; Keens TG
Pediatrics; 1988 May; 81(5):635-42. PubMed ID: 3357725
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis.
Schmölzer GM; Kumar M; Pichler G; Aziz K; O'Reilly M; Cheung PY
BMJ; 2013 Oct; 347():f5980. PubMed ID: 24136633
[TBL] [Abstract][Full Text] [Related]
10. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
[TBL] [Abstract][Full Text] [Related]
11. Environmental or Nasal Cannula Supplemental Oxygen for Preterm Infants: A Randomized Cross-Over Trial.
Travers CP; Carlo WA; Nakhmani A; Bhatia S; Gentle SJ; Amperayani VA; Indic P; Aban I; Ambalavanan N
J Pediatr; 2018 Sep; 200():98-103. PubMed ID: 29705116
[TBL] [Abstract][Full Text] [Related]
12. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
[TBL] [Abstract][Full Text] [Related]
13. Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
Bassler D; Plavka R; Shinwell ES; Hallman M; Jarreau PH; Carnielli V; Van den Anker JN; Meisner C; Engel C; Schwab M; Halliday HL; Poets CF;
N Engl J Med; 2015 Oct; 373(16):1497-506. PubMed ID: 26465983
[TBL] [Abstract][Full Text] [Related]
14. Neonatal intermittent hypoxemia events are associated with diagnosis of bronchopulmonary dysplasia at 36 weeks postmenstrual age.
Raffay TM; Dylag AM; Sattar A; Abu Jawdeh EG; Cao S; Pax BM; Loparo KA; Martin RJ; Di Fiore JM
Pediatr Res; 2019 Feb; 85(3):318-323. PubMed ID: 30538265
[TBL] [Abstract][Full Text] [Related]
15. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
Trials; 2023 May; 24(1):320. PubMed ID: 37161488
[TBL] [Abstract][Full Text] [Related]
16. Bronchopulmonary dysplasia in a premature infant--case report and literature review.
George IO; Frank-Briggs AI; Nyengidiki TK
Niger J Med; 2010; 19(1):108-11. PubMed ID: 20232765
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of inpatient polysomnogram characteristics and discharge outcomes in infants with bronchopulmonary dysplasia requiring home oxygen therapy.
Flores-Fenlon N; Wright N; Lew C; Stavroudis TA; Wee CP; Davidson Ward SL; Bansal M
Pediatr Pulmonol; 2021 Jan; 56(1):88-96. PubMed ID: 33107696
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates.
Isayama T; Lee SK; Yang J; Lee D; Daspal S; Dunn M; Shah PS;
JAMA Pediatr; 2017 Mar; 171(3):271-279. PubMed ID: 28114678
[TBL] [Abstract][Full Text] [Related]
19. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
[TBL] [Abstract][Full Text] [Related]
20. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
